Abnormal umbilical artery Doppler waveforms and cord blood corticotropin-releasing hormone

被引:54
|
作者
Giles, WB
McLean, M
Davies, JJ
Smith, R
机构
[1] Maternal Health Research Centre, John Hunter Hospital, Newcastle, NSW
[2] John Hunter Hosp-Matern. Hlth. R., Hunter Region Mail Exchange, Newcastle, NSW 2310
来源
OBSTETRICS AND GYNECOLOGY | 1996年 / 87卷 / 01期
关键词
D O I
10.1016/0029-7844(95)00338-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine whether placental secretion of corticotropin-releasing hormone into the fetal circulation is increased in pregnancies complicated by umbilical-placental vascular insufficiency. Methods: Twenty women with abnormal Doppler umbilical artery flow velocity waveforms and six women with uncomplicated term pregnancies and normal umbilical artery now velocity waveforms had cord blood concentrations of corticotropin-releasing hormone, ACTH, cortisol, and beta-hCG estimated. Results: The mean cord blood colticotropin-releasing hormone concentration was significantly higher in pregnancies with abnormal umbilical artery now velocity waveforms than in normal pregnancies (108 +/- 27 versus 24 +/- 8 pg/mL, P =.019). Elevated cord blood corticotropin-releasing hormone levels were seen in the abnormal group regardless of the presence or absence of preeclampsia or fetal growth restriction. There were no significant differences in cord blood cortisol, ACTH, or beta-hCG concentrations. Conclusion: The concentration of corticotropin-releasing hormone in the fetal circulation is significantly increased in pregnancies complicated by abnormal umbilical artery now velocity waveforms. This may represent a stress-responsive compensatory mechanism in the human placenta.
引用
收藏
页码:107 / 111
页数:5
相关论文
共 50 条
  • [41] Corticotropin-releasing hormone treatment for major depression
    Joachim F. Hallmayer
    Current Psychiatry Reports, 2002, 4 (3) : 163 - 164
  • [42] CORTICOTROPIN-RELEASING FACTOR - AN ANTIREPRODUCTIVE HORMONE OF THE TESTIS
    DUFAU, ML
    TINAJERO, JC
    FABBRI, A
    FASEB JOURNAL, 1993, 7 (02): : 299 - 307
  • [43] CORTICOTROPIN-RELEASING HORMONE AND ITS VASOPRESSIN COMPONENT
    GILLIES, G
    LOWRY, PJ
    FRONTIERS IN NEUROENDOCRINOLOGY, 1982, 7 : 45 - 75
  • [44] Corticotropin-releasing hormone (CRH) and immunotolerance of the fetus
    Makrigiannakis, A
    Zoumakis, E
    Kalantaridou, S
    Mitsiades, N
    Margioris, A
    Chrousos, GP
    Gravanis, A
    BIOCHEMICAL PHARMACOLOGY, 2003, 65 (06) : 917 - 921
  • [45] Induction of microglial apoptosis by corticotropin-releasing hormone
    Ock, Jiyeon
    Lee, Heasuk
    Kim, Sangseop
    Lee, Won-Ha
    Choi, Dong-Kug
    Park, Eun Jung
    Kim, Sang-Hyun
    Kim, In Kyeom
    Suk, Kyoungho
    JOURNAL OF NEUROCHEMISTRY, 2006, 98 (03) : 962 - 972
  • [46] Corticotropin-releasing hormone binding to the syncytiotrophoblast membranes
    Saeed, B
    Fawcett, M
    Self, C
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2001, 31 (02) : 125 - 130
  • [47] CORTICOTROPIN-RELEASING HORMONE TESTING IN PITUITARY DISEASE
    LORIAUX, DL
    NIEMAN, L
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1991, 20 (02) : 363 - 369
  • [48] HUMAN CORTICOTROPIN-RELEASING HORMONE DURING PREGNANCY
    STALLA, GK
    BOST, H
    STALLA, J
    KALIEBE, T
    DORR, HG
    PFEIFFER, D
    VONWERDER, K
    MULLER, OA
    GYNECOLOGICAL ENDOCRINOLOGY, 1989, 3 (01) : 1 - 10
  • [49] Potential uses of corticotropin-releasing hormone antagonists
    Zoumakis, E.
    Rice, K. C.
    Gold, P. W.
    Chrousos, G. P.
    STRESS, OBESITY, AND METABOLIC SYNDROME, 2006, 1083 : 239 - 251
  • [50] PLACENTAL CORTICOTROPIN-RELEASING HORMONE - THERE BY ACCIDENT OR DESIGN
    PERKINS, AV
    LINTON, EA
    JOURNAL OF ENDOCRINOLOGY, 1995, 147 (03) : 377 - 381